TNA

Flash News: OKX Wallet Now Integrated with TNA Protocol for Enhanced Blockchain Name Services

Retrieved on: 
Thursday, January 25, 2024
Bitcoin, Web3, Firefox, TNA, OKX, Chrome, Cryptocurrency

OKX Wallet is now integrated with TNA Protocol , a protocol for issuing and managing Tapnames - Bitcoin-native name assets based on the Taproot Assets Protocol ("TAP").

Key Points: 
  • OKX Wallet is now integrated with TNA Protocol , a protocol for issuing and managing Tapnames - Bitcoin-native name assets based on the Taproot Assets Protocol ("TAP").
  • This strategic integration enables OKX Wallet's web extension users to issue and manage Tapnames, enhancing their interaction with the Bitcoin ecosystem.
  • This collaboration aligns with OKX Wallet's commitment to providing its users with innovative solutions that enhance their Web3 experience.
  • OKX Wallet users can now access TNA Protocol by downloading the OKX Wallet web extension available on Chrome and Firefox, creating or adding an existing OKX Wallet, and connecting it to TNA Protocol via the web extension.

Integrated DNA Technologies Launches New Archer™ FUSIONPlex™ Core Solid Tumor Panel for Cancer Research

Retrieved on: 
Monday, April 17, 2023
Other Health, Research, General Health, Oncology, Other Manufacturing, Genetics, Health Technology, Science, Biotechnology, Manufacturing, Other Science, Health, Neoplasm, TNA, Integrated DNA Technologies, Cancer, RNA, VP/CSS, Genomics, Multimedia, Biomarker, IDT, Archery, SNV, Integration, Gene, GSP, Medical imaging, Vaccine

Integrated DNA Technologies (IDT), a global genomics solutions provider, is supporting research labs worldwide with a new solution to optimize operational efficiency and the identification of solid cancer tumors.

Key Points: 
  • Integrated DNA Technologies (IDT), a global genomics solutions provider, is supporting research labs worldwide with a new solution to optimize operational efficiency and the identification of solid cancer tumors.
  • View the full release here: https://www.businesswire.com/news/home/20230417005033/en/
    Integrated DNA Technologies is supporting research labs worldwide with a new solution to optimize operational efficiency and the identification of solid cancer tumors.
  • The Archer FUSIONPlex Core Solid Tumor Panel provides a new approach to researchers looking for an alternative to current methods, which require running a minimum of two assays—one DNA- and one RNA-based—to address comprehensive profiling research.
  • The FUSIONPlex Core Solid Tumor Panel is a balanced pool of gene-specific primer (GSP) oligonucleotides targeting 56 genes.

BD, CerTest Biotec Announce Emergency Use Authorization for Mpox Diagnostic Test

Retrieved on: 
Monday, January 9, 2023
TNA, Food, Emergency Use Authorization, Urinary tract infection, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Molecular diagnostics, Research, World Health Organization's response to the COVID-19 pandemic, Becton, Disease, NYSE, Infection, EUA, Becton, Dickinson and Company headquarters, Health, FDA, BD, BDX, Vaccine, Diagnosis, PCR, Pharmaceutical industry, Computer data storage

FRANKLIN LAKES, N.J., Jan. 9, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec have announced Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a molecular polymerase chain reaction (PCR) assay for Mpox virus detection.

Key Points: 
  • The VIASURE Monkeypox Virus Real Time PCR Reagents for BD MAX System* is now available for BD MAX™ System users.
  • "The Mpox outbreak continues to be designated as a global health emergency — the World Health Organization's highest level of alert," said Nikos Pavlidis, vice president of Molecular Diagnostics at BD.
  • "We were able to quickly develop the VIASURE mpox molecular test by leveraging the BD MAX™ System's open system reagent suite," said Nelson Fernandes, managing director of CerTest Biotec.
  • As with all CerTest assays, the VIASURE Monkeypox Virus PCR Detection assay for the BD MAX™ System is offered in a lyophilized format.

Hall of Fame Wrestler and Cannabis Pioneer Rob Van Dam to Launch RVD Cannabis Brand in California Through Licensing Deal with Grapefruit USA, Inc.

Retrieved on: 
Thursday, September 29, 2022
Cream, Health, Pro Wrestling Illustrated, WWE Hall of Fame, Impact Wrestling, PRO, Cannabis, CBD, OTCQB, Company, TNA, WWE, ECW, Private Securities Litigation Reform Act, Partnership, Recession, U.S. Securities and Exchange Commission, Patient, Risk, History, Golden State, Grapefruit, Form, Security (finance), GLOBE, RVD, Drug, Film, Online shopping

Van Dam is one of only two wrestlers in history to have held theWWE,ECW and TNAworld championships.

Key Points: 
  • Van Dam is one of only two wrestlers in history to have held theWWE,ECW and TNAworld championships.
  • He was voted "Most Popular Wrestler" by readers of Pro Wrestling Illustrated magazine in 2001 and again in 2002.
  • Our strategic partnership with Rob Van Dam and his team is a natural fit.
  • His cannabis brand, RVD, has an advantage that other cannabis products lack and fits the new Cannabis 3.0 environment, which is all about creating exciting and popular branded cannabis and hemp-based products.

BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay

Retrieved on: 
Monday, September 26, 2022
Becton, Molecular diagnostics, Health, Therapy, EUA, Laboratory, Safety, Infection, Efficiency, COVID-19, Twitter, BDX, NYSE, Becton, Dickinson and Company headquarters, FDA, Monkeypox virus, Food, Organization, LinkedIn, Company, TNA, Urinary tract infection, Monkeypox, Office of Inspector General, U.S. Department of Health and Human Services, Patient, Human services, Public health, Solution, Research, PCR, BD, Disease, Pharmaceutical industry

FRANKLIN LAKES, N.J., Sept. 26, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec today announced their newly developed molecular polymerase chain reaction (PCR) assay for monkeypox virus is now commercially available globally, including in the United States, for research use only applications by laboratories.

Key Points: 
  • The teams leveraged the BD MAX System open architecture reagent suite to develop the CerTest VIASURE Monkeypox molecular research use only assay.
  • "This new test boosts capacity for monkeypox research and surveillance of this global health emergency," said Nelson Fernandes, managing director of CerTest Biotec.
  • As with all CerTest assays, the CerTest VIASURE Monkeypox virus PCR Detection RUO assay for the BD MAX System is offered in a lyophilized format.
  • CerTest Biotec is a European company established in 2002 for the development and manufacturing of in vitro diagnostic medical devices.

TNF Alpha Inhibitors Global Market Research Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Monday, August 1, 2022
Health, Pharmaceutical, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Certolizumab pegol, Warfarin necrosis, Etanercept, IBD, Immune-mediated inflammatory diseases, Inflammation, Infliximab, Tuberculosis, UC, TNF, Dermatology, Food, Blastomycosis, Rheumatoid arthritis, Janssen Biotech, Crohn's disease, Ulcerative colitis, Tumor necrosis factor, Histoplasmosis, AbbVie, Disease, Inflammatory bowel disease, Rheumatology, Person, Eastman Kodak Co. v. Image Technical Services, Inc., Gastroenterology, Pfizer, Ankylosing spondylitis, Hepatitis, Candidiasis, RA, TNA, FDA, Spondyloarthropathy, Patient, Psoriasis, Adalimumab, Overalls, Growth, Infection, Neutropenia, Amgen, Prevalence, UCB, Pharmaceutical industry, Lithium, Ablynx

The "TNF Alpha Inhibitors Global Market Report 2022: By Drug, By Route, By Disease" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "TNF Alpha Inhibitors Global Market Report 2022: By Drug, By Route, By Disease" report has been added to ResearchAndMarkets.com's offering.
  • The TNF alpha inhibitors market consists of sales of tumor necrosis factor-alpha (TNF-a) inhibitors by entities that manufacture TNF alpha inhibitors.
  • The adverse side effects of TNF alpha inhibitors on patients are expected to limit the growth of the TNF alpha inhibitors market.
  • Global TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

BD, CerTest Biotec Announce Commercial Launch of Monkeypox Test

Retrieved on: 
Wednesday, July 27, 2022
Monkeypox virus, World, Laboratory, Twitter, Molecular diagnostics, NYSE, Research, BDX, Solution, Health, Monkeypox, Safety, COVID-19, World Health Organization, Urinary tract infection, Organization, Becton, TNA, Disease, Company, Patient, LinkedIn, Efficiency, Therapy, Infection, PCR, BD, Becton, Dickinson and Company headquarters, Pharmaceutical industry, Computer data storage, Vaccine

FRANKLIN LAKES, N.J., July 27, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec today announced their newly developed molecular polymerase chain reaction (PCR) test for the monkeypox virus is now commercially available outside of the United States for use in research applications by laboratories.

Key Points: 
  • The assay leveraged the BD MAX System open system reagent suite to develop the CerTest VIASURE Monkeypox molecular test on the BD MAX System.
  • "We hope this new test will boost capacity for monkeypox research, ultimately helping quell the spread of the disease."
  • As with all CerTest tests, the Monkeypox PCR Detection Kit for the BD MAX System is offered in a lyophilized format.
  • CerTest Biotec is a European company established in 2002 for the development and manufacturing of in vitro diagnostic medical devices.

American Nurses Association Reacts to Sentencing of Nurse RaDonda Vaught

Retrieved on: 
Friday, May 13, 2022
Nursing, Death, Risk, Spring, Leadership, Violence, Approximation error, Patient, Occupational Safety and Health Act 1994, Health, Hearing, COVID-19, American Nurses Association, Adult, Culture, Tennessee Nurses Association, Vanderbilt University Medical Center, Infection, Communication, Letter, TNA, GLOBE, Medicine, MD

The following statement is attributable to both the American Nurses Association (ANA) and the Tennessee Nurses Association (TNA) :

Key Points: 
  • The following statement is attributable to both the American Nurses Association (ANA) and the Tennessee Nurses Association (TNA) :
    We are grateful to the judge for demonstrating leniency in the sentencing of Nurse Vaught.
  • In fact, leading up to the sentencing hearing, ANA was in communication with Vaught and her attorney to discuss the best ways for ANA to provide support to Vaught in the specific context of sentencing.
  • Nurses see themselves in Vaught; our peers and colleagues and health care professionals beyond nursing see themselves in Vaught.
  • The American Nurses Association (ANA) is the premier organization representing the interests of the nation's 4.3 million registered nurses.

Toyota North America Announces Executive Changes

Retrieved on: 
Friday, December 10, 2021
Lexus NX, Matam, Marketing, TFS, Toyota Motor North America, Manufacturing engineering, TM, TMMK, Cooke, TRD, Toyota Motor Manufacturing Canada, TNA, Farrell, Gupta, Toyota Financial Services, Engineering, TMNA, Wilson, Shared services, Toyota Racing Development, NYSE, Rosier, Toyota bZ4X, Motor vehicle, Management

PLANO, Texas, Dec. 10, 2021 /PRNewswire/ -- Toyota North America (TNA) today announced executive changes to Toyota Motor North America (TMNA) and Toyota Financial Services (TFS), with the aim to drive critical business needs in support of TNA's mobility strategy.

Key Points: 
  • PLANO, Texas, Dec. 10, 2021 /PRNewswire/ -- Toyota North America (TNA) today announced executive changes to Toyota Motor North America (TMNA) and Toyota Financial Services (TFS), with the aim to drive critical business needs in support of TNA's mobility strategy.
  • Earlier this year, Toyota announced plans to debut three new electrified models in the U.S. in 2021including the Toyota bZ4X and Lexus NX 450h+ and took a major step forward with a $1.29 billion investment in an automotive battery manufacturing plant in North Carolina, called Toyota Battery Manufacturing, North Carolina (TBMNC).
  • Toyota (NYSE:TM) has been a part of the cultural fabric in North America for more than 60 years, and is committed to advancing sustainable, next-generation mobility through our Toyota and Lexus brands plus our 1,800 dealerships.
  • Toyota has created a tremendous value chain and directly employs more than 47,000 in North America.

TNF Alpha Inhibitors Global Markets Research Report 2021: Focus on Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol), & Simponi (golimumab) - ResearchAndMarkets.com

Retrieved on: 
Monday, December 6, 2021
Health, Pharmaceutical, Patient, Growth, Ankylosing spondylitis, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Psoriasis, Crohn's disease, Rheumatology, Hepatitis, Inflammation, Overalls, Tuberculosis, Rheumatoid arthritis, Adalimumab, Neutropenia, Candidiasis, Prevalence, Dermatology, Histoplasmosis, Janssen Biotech, Etanercept, District Co-operative Central Bank, AbbVie, Pfizer, Warfarin necrosis, RA, Food, COVID-19, IBD, Infliximab, UCB, Inflammatory bowel disease, UC, Certolizumab pegol, Ulcerative colitis, Blastomycosis, Infection, Amgen, FDA, Tumor necrosis factor, TNA, Spondyloarthropathy, Gastroenterology, TNF, Immune-mediated inflammatory diseases, Pharmaceutical industry

The "TNF Alpha Inhibitors Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "TNF Alpha Inhibitors Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The TNF alpha inhibitors market consists of sales of tumor necrosis factor-alpha (TNF-?)
  • The TNF alpha inhibitors market covered in this report is segmented by drug into remicade (infliximab), enbrel (etanercept), humira (adalimumab), cimzia (certolizumab pegol), simponi (golimumab).
  • The adverse side effects of TNF alpha inhibitors on patients are expected to limit the growth of the TNF alpha inhibitors market.